Abstract
The relevance of the study is due to the fact that global R&D spending in the pharmaceutical industry continues to grow every year, but the effectiveness of R&D is reduced. The pharmaceutical development process is the first and very important stage in the development of the new drug substance. The purpose of the study is to study the modern structure of the organization of pharmaceutical developments in large pharmaceutical companies. In the study, the authors used a systematic approach, inductive analysis, deductive analysis, content analysis method, comparison method. The study identified the main participants in the pharmaceutical development process in large pharmaceutical companies.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Association of Russian Pharmaceutical Manufacturers: Projects (n.d.). http://www.arfp.ru/proekty/partnering/
BAYER: Research and development (n.d.). https://www.bayer.com/en/research-and-development.aspx
EFPIA: Development of medicines: Explore the process of medicine development (n.d.). https://efpia.eu/about-medicines/development-of-medicines/
European Medicines Agency: Medicines (n.d.). https://www.ema.europa.eu/en/medicines
FDA: Development & approval process (n.d.). https://www.fda.gov/drugs/development-approval-process-drugs
ICH: Process of harmonization (n.d.). https://ich.org/page/process-harmonisation
JPMA: Official website (n.d.). https://jpma.or.jp/english/
Kovshova, M.V., Bryzgalova, E.A.: Pharmaceutical Industry of Russia on the Way to Transformation, Modern Development Trends. Nauchnyj konsul’tant, Moscow (2019)
McKinsey Global Institute: Official website (n.d.). https://mckinsey.com/mgi/overview
Ministry of Health of the Russian Federation: Structure (n.d.). https://rosminzdrav.ru/
Ministry of health, labor, social security of Japan: Official website (n.d.). https://mhlw.go.jp/english/
Novartis Institutes for Biomedical Research: Major discovery efforts at the frontiers of science (n.d.). https://www.novartis.com/our-science/novartis-institutes-biomedical-research
Pharmaceutical development: Q8(R2) from August, 2009. Brussels, EU: ICH (2009)
PhRMA: Official website (n.d.). https://phrma.org
PWC: Pharmaceuticals (n.d.). https://pwc.com/gx/en/industries/pharmaceuticals-life-sciences.html
SANOFI: Research and development (n.d.). https://www.sanofi.com/en/science-and-innovation/research-and-development
Scannell, J.W., Blanckley, A., Boldon, H., Warrington, B.: Diagnosing the decline in pharmaceutical R&D efficiency. Nat. Rev. Drug Discov. 11(3), 191–200 (2012). pmid:22378269
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2021 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Bryzgalova, E.A., Kovshova, M.V., Kolesnikova, O.V., Larina, L.B., Zhukova, O.I. (2021). Cooperation in Pharmaceutical Development. In: Bogoviz, A.V., Suglobov, A.E., Maloletko, A.N., Kaurova, O.V., Lobova, S.V. (eds) Frontier Information Technology and Systems Research in Cooperative Economics. Studies in Systems, Decision and Control, vol 316. Springer, Cham. https://doi.org/10.1007/978-3-030-57831-2_86
Download citation
DOI: https://doi.org/10.1007/978-3-030-57831-2_86
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-57830-5
Online ISBN: 978-3-030-57831-2
eBook Packages: Intelligent Technologies and RoboticsIntelligent Technologies and Robotics (R0)